Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritisCentriole polarisation to the immunological synapse directs secretion from cytolytic cells of both the innate and adaptive immune systemsStructure of human CD1b with bound ligands at 2.3 A, a maze for alkyl chainsThe crystal structure of human CD1b with a bound bacterial glycolipidImmune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infectionRegulation of Lipid Specific and Vitamin Specific Non-MHC Restricted T Cells by Antigen Presenting Cells and Their Therapeutic PotentialsMR1-Restricted Mucosal-Associated Invariant T Cells and Their Activation during Infectious DiseasesThe actin cytoskeleton modulates the activation of iNKT cells by segregating CD1d nanoclusters on antigen-presenting cells.Ca2+ release from the endoplasmic reticulum of NY-ESO-1-specific T cells is modulated by the affinity of TCR and by the use of the CD8 coreceptor.Structures of an MHC class I molecule from B21 chickens illustrate promiscuous peptide bindingRational development of high-affinity T-cell receptor-like antibodiesThe VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivoPresentation of viral antigen controlled by a gene in the major histocompatibility complexInvariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid AGlobosides but not isoglobosides can impact the development of invariant NKT cells and their interaction with dendritic cellsInvariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humansCharacterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursorsQuantitating T cell cross-reactivity for unrelated peptide antigensAn open invitation to the cancer immunology communityCD169(+) macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes.The location of splenic NKT cells favours their rapid activation by blood-borne antigen.In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes.Phage display-derived recombinant antibodies with TCR-like specificity against alpha-galactosylceramide and its analogues in complex with human CD1d molecules.[Glycosphingolipids Gb3 and iGb3. In vivo roles in hemolytic-uremic syndrome and iNKT cell function].Linking inflammation to natural killer T cell activation.Rational design of indoleamine 2,3-dioxygenase inhibitors.Improved localization of cellular membrane receptors using combined fluorescence microscopy and simultaneous topography and recognition imaging.Lytic versus stimulatory synapse in cytotoxic T lymphocyte/target cell interaction: manifestation of a dual activation thresholdA dominant role for the immunoproteasome in CD8+ T cell responses to murine cytomegalovirusDependence of T cell antigen recognition on T cell receptor-peptide MHC confinement time.BCL6b mediates the enhanced magnitude of the secondary response of memory CD8+ T lymphocytes.Human T-cell leukemia virus type 1 Tax protein binds to assembled nuclear proteasomes and enhances their proteolytic activity.Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells.TAP deficiency syndrome.Primary deficiency of microsomal triglyceride transfer protein in human abetalipoproteinemia is associated with loss of CD1 function.Antigen potency and maximal efficacy reveal a mechanism of efficient T cell activation.T cell receptor CDR2 beta and CDR3 beta loops collaborate functionally to shape the iNKT cell repertoireGene therapy meets vaccine development.Constitutively active Lck kinase in T cells drives antigen receptor signal transductionTracking T cells with tetramers: new tales from new tools.
P50
Q21128781-659F7AFD-C8D1-4477-85FE-C06BC74C1DB5Q21245308-E944B56C-2FD1-49B2-8565-4E52C661FE12Q24301525-87B56AAE-EF3A-4FE5-91E3-00827B1DDBA1Q24307448-91E6FC86-6491-4693-953B-4595F36EFFB1Q24795912-06DA52C0-DE82-4C80-A83A-7F3B00A05670Q26797333-1888EB64-8129-4A91-B212-980810B56D0BQ26852490-57B0CECE-6640-471A-B9A7-7B2CD35817D2Q27319157-60707662-2DD3-4FB9-87E4-32C8F3F97ADDQ27646628-B7ADBC77-ED92-41E1-BCF5-6EDB87DDFC46Q27649329-A30A1338-9A94-44BA-9BC6-2E67B0E22402Q27654241-530FBD1E-E226-4DA6-AA8C-41D646CC17CBQ28243922-C76538EA-5999-48A6-9F4A-B622A39018EBQ28285937-C2E9FF27-C3B3-4B08-8B16-DD2EE60910BBQ28294740-939378A5-121D-41FB-B4F5-1F06CD7F6EFEQ28505051-9B7D04C0-B561-4E88-830F-7E02598BD546Q28511526-C2C8E8E0-BD81-455C-BBF4-7B1DA4A01ECAQ28585599-A7BF380B-621A-4E15-AC48-8D4FC2BE6343Q28750512-D8AAAA22-BA54-4580-A647-A32B1FD526F0Q30485642-CEFFE41A-F91E-4D26-A217-463435CB34A2Q30496134-36858041-ABB3-4EA2-A61A-FE1218FA2167Q30514281-65DD13CA-8F15-4190-87B1-C60192C1DE00Q33178945-37FFA6D6-FDC5-48C8-9CB9-70A4D1450922Q33318487-E5311B95-2CDE-4E15-AC14-396C89C86ACAQ33381259-7A659A04-9727-42C3-97DF-F8F100F269CBQ33512902-7048C997-4C3B-4C2A-B2EC-649D50DF430EQ33522429-915272C4-0C6F-46FE-B1C7-1D9093296C27Q33533000-F6B9EB88-F2AB-4F5F-8AF1-0ACF9575F2DCQ33715565-E79E658C-F673-454F-9168-61BD96C94D91Q33815471-926E2E80-B3BF-4567-B23D-3A7EACF9DF61Q33821395-E3B09941-EF4A-4455-8D8C-F2385751AF01Q33836309-E2F60A6A-2EE1-4555-BCA3-753142D6CC43Q33849258-FEB8B19B-02F3-4658-BA88-51B67FB87568Q33902421-B4AA8598-4355-4F53-BC4C-80C2B144E190Q33994458-54CF4383-7797-47DD-A8C0-1DBE80DD6841Q34028751-61CBD51E-BF31-4D9F-8059-452B6EA0198FQ34086610-0AF367FD-8696-423F-BB65-97FA104BBA4DQ34245603-3365E474-A1F1-4A80-83EC-5F628D522E05Q34367432-3AA94A89-B59E-4EAD-85EA-2E97E9975180Q34376930-CA626C26-9DBB-4649-96E2-96CC625AB959Q34632077-24BAC1EB-E828-44B0-95B3-DCC9A2A38835
P50
description
Brits onderzoeker (1959-2020)
@nl
Italian medical researcher
@en
name
Vincenzo Cerundolo
@ast
Vincenzo Cerundolo
@en
Vincenzo Cerundolo
@es
Vincenzo Cerundolo
@nl
Vincenzo Cerundolo
@sl
type
label
Vincenzo Cerundolo
@ast
Vincenzo Cerundolo
@en
Vincenzo Cerundolo
@es
Vincenzo Cerundolo
@nl
Vincenzo Cerundolo
@sl
altLabel
Enzo Cerundolo
@en
prefLabel
Vincenzo Cerundolo
@ast
Vincenzo Cerundolo
@en
Vincenzo Cerundolo
@es
Vincenzo Cerundolo
@nl
Vincenzo Cerundolo
@sl
P106
P1153
7006644170
P19
P2070
vincenzo-cerundolo-13802
P21
P31
P496
0000-0003-0040-3793
P509
P569
1959-12-20T00:00:00Z
P570
2020-01-07T00:00:00Z